Section 211. As used in this section and sections 212 to 219, inclusive, the following words shall, unless the context otherwise requires, have the following meanings:-
“American Board of Cardiovascular Perfusion”, the national agency for certification and recertification of clinical perfusionists.
“Board”, the board of registration in perfusion established in section 11E of chapter 13.
“Extracorporeal circulation”, the diversion of a patient’s blood through a heart-lung machine or a similar device that assumes the functions of the patient’s heart, lungs, kidneys, liver or other organs.
“Licensed perfusionist”, a person licensed under sections 212 to 219, inclusive.
“Perfusion”, the functions necessary for the support, treatment, measurement or supplementation of the cardiovascular, circulatory or respiratory system or other organs or a combination of those activities and to ensure the safe management of physiologic functions by monitoring and analyzing the parameters of the systems under an order and under the supervision of a licensed physician including:
(1) the use of extracorporeal circulation, long-term cardiopulmonary support techniques including extracorporeal carbon dioxide removal and extracorporeal membrane oxygenation and associated therapeutic and diagnostic technologies;
(2) counterpulsation, ventricular assistance, autotransfusion, blood conservation techniques, myocardial and organ preservation, extracorporeal life support and isolated limb perfusion;
(3) the use of techniques involving blood management, advanced life support and other related functions; and
(4) in the performance of the acts described in this clause:
(i) the administration of pharmacological and therapeutic agents or blood products through the extracorporeal circuit or through an intravenous line as ordered by a physician and the administration of anesthetic agents through the extracorporeal circuit or through an intravenous line as ordered by and under the supervision of an anesthesiologist;
(ii) the performance and use of anticoagulation monitoring and analysis, physiologic monitoring and analysis, blood gas and chemistry monitoring and analysis, hematological monitoring and analysis, hypothermia, hyperthermia, hemoconcentration, hemofiltration and hemodilution;
(iii) the observation of signs and symptoms related to perfusion services, the determination of whether the signs and symptoms exhibit abnormal characteristics and the implementation of appropriate reporting, perfusion protocols or changes in or the initiation of emergency procedures.
“Perfusion protocols”, perfusion-related policies and protocols developed or approved by a licensed health care facility or a physician through collaboration with administrators, licensed perfusionists and other health care professionals.
“Provisional licensed perfusionist”, a person provisionally licensed under sections 213 to 219, inclusive.